Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BioLineRx Ltd. BLRX

BioLine Rx Ltd is a clinical-stage biopharmaceutical development company with a strategic focus on oncology. Its development and commercialization pipeline consists of two clinical-stage therapeutic candidates - Motixafortide, a novel peptide for the treatment of solid tumors, hematological malignancies and stem cell mobilization, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, it has an off- strategy, a legacy therapeutic product called BL-5010 for the...

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:BLRX)

Fundamentals Snapshot (NDAQ:BLRX)

Current News (NDAQ:BLRX)

BLRX Investors Have Opportunity to Lead BioLineRx Ltd. Securities Fraud Lawsuit

PR Newswire 19 hours ago

ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX

PR Newswire 20 hours ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioLineRx Ltd. - BLRX

Newsfile 2 days ago

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX

Newsfile 4 days ago

ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX

PR Newswire 6 days ago

BioLineRx Ltd. (BLRX) Shareholder Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against BioLineRx Ltd.

Business Wire 7 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioLineRx Ltd. - BLRX

PR Newswire 8 days ago

BLRX Investors Have Opportunity to Lead BioLineRx Ltd. Securities Fraud Lawsuit

PR Newswire 9 days ago

ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX

Newsfile 10 days ago

Opinion & Analysis (NDAQ:BLRX)

No current opinion is available.

Bullboard Posts (NDAQ:BLRX)

RE:RE:RE:Entry here

There she goes!!!  Patience pays!!!!
mevani - July 2, 2021

RE:RE:Entry here

Patience pays!
mevani - July 1, 2021

RE:Entry here

I am adding here.   
mevani - May 5, 2021

Dang ......

can't win em all
Iseneschal - May 4, 2021

RE:Entry here

Got to be quick.......taking anything it gives me  No position
Iseneschal - May 4, 2021

Entry here

1 st position
Iseneschal - May 4, 2021